Author

Roxanne Kapikian

Observed institutions: Nebraska Medical Center, GlaxoSmithKline (United States)

OpenAlex ID: A5072015413

Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24‐Week Randomized, Placebo‐Controlled, Multicenter Trial

2011 · Steven R. Smith, Kaj S. Stenlof, et al. · Obesity · 54

Effect of two dietary fibers on satiety and glycemic parameters: a randomized, double-blind, placebo-controlled, exploratory study

2014 · David M Savastano, Rebecca J Hodge, et al. · Nutrition Journal · 22

Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic Setting

2018 · Mitchell Nides, Tobias Danielsson, et al. · Nicotine & Tobacco Research · 13

212 Teduglutide, a Novel GLP-2 Analog, in the Management of Short Bowel Syndrome (SBS) Patients Dependent On Parenteral Nutrition: A Multicenter, Multinational Placebo-Controlled Clinical Trial

2008 · Stephen J. O'Keefe, Richard Gilroy, et al. · Gastroenterology · 9

Efficacy and Safety of Teduglutide in Parenteral Nutrition (PN)-Dependent SBS Subjects: Update of a Current Multinational Trial

2007 · Richard Gilroy, Nonko Pehlinov, et al. · The American Journal of Gastroenterology

Works count: 5

Citation count: 98

H-index: 4

I10-index: 3